LncRNA ‐ HCP5 Regulates KLF5 by ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis
International Journal of Rheumatic Diseases · 2025
DOI: 10.1111/1756-185x.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Peng Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Shaanxi Rehbilitation Hospital, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, MicroRNAs, Kruppel-Like Transcription Factors, Osteoarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Osteoarthritis (OA) is one of the most common bone disorders and has a serious impact on the quality of life of patients. LncRNA‐HCP5 (HCP5) is downregulated in OA tissues. However, the latent function and regulatory mechanisms of HCP5 in OA are unclear.
Methods
In the current study, IL‐1β‐induced C28/I2 cells were used to establish an in vitro model of OA. The expression of HCP5 in OA cartilage tissue and in the in vitro model of OA was detected by RT‐qPCR. Cell viability and apoptosis were assessed by CCK‐8 and Annexin V‐PI double staining. Western blotting was employed to detect the protein expression of MMP‐13 and aggrecan.
Results
The results showed that the findings suggested that HCP5 was downregulated in OA cartilage tissue and IL‐1β‐induced C28/I2 cells. HCP5 overexpression greatly enhanced IL‐1β‐induced proliferation of C28/I2 cells, as well as prevented cell apoptosis and degradation of extracellular matrix (ECM). Besides, we have shown that HCP5 is a ceRNA that regulates KLF5 by sponging miR‐375. Furthermore, KLF5 is also regulated by m6A regulation induced by HCP5. Finally, overexpression of miR‐375, the m6A modification inhibitor, as well as KLF5 inhibition reversed the impact of HCP5 on IL‐1β‐induced C28/I2 cells.
Conclusion
In summary, the present study demonstrated that the HCP5/KLF5 axis inhibited the progression of osteoarthritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Shaanxi Rehbilitation Hospital, Xi'an, Shaanxi, China.
- Department of Occupational Therapy, Shaanxi Rehbilitation Hospital, Xi'an, Shaanxi, China.
ORCID-Profile: Jiyang Zhang
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Jiang, P., Song, Y., Li, P., Yang, Y., & Zhang, J. (2025). LncRNA ‐ HCP5 Regulates KLF5 by ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70035
Vancouver
Jiang P, Song Y, Li P, Yang Y, Zhang J. LncRNA ‐ HCP5 Regulates KLF5 by ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70035
BibTeX
@article{Jiang2025,
author = {Jiang, Peng and Song, Yuxuan and Li, Pengfei and Yang, Yanhui and Zhang, Jiyang},
title = {LncRNA ‐ HCP5 Regulates KLF5 by ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis},
journal = {International Journal of Rheumatic Diseases},
year = {2025},
doi = {10.1111/1756-185x.70035}
}
EUVIMED